Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure by Flora, Swaran JS
[Oxidative Medicine and Cellular Longevity 2:4, 191-206; September/October 2009]; ©2009 Landes Bioscience
Oxidative stress contributes to the pathophysiology of expo-
sure  to  heavy  metals/metalloid.  Beneficial  renal  effects  of 
some  medications,  such  as  chelation  therapy  depend  at  least 
partially on the ability to alleviate oxidative stress. The admin-
istration of various natural or synthetic antioxidants has been 
shown  to  be  of  benefit  in  the  prevention  and  attenuation  of 
metal induced biochemical alterations. These include vitamins, 
N-acetylcysteine,  α-lipoic  acid,  melatonin,  dietary  flavonoids 
and  many  others.  Human  studies  are  limited  in  this  regard. 
Under certain conditions, surprisingly, the antioxidant supple-
ments may exhibit pro-oxidant properties and even worsen metal 
induced toxic damage. To date, the evidence is insufficient to 
recommend antioxidant supplements in subject with exposure 
to  metals.  Prospective,  controlled  clinical  trials  on  safety  and 
effectiveness of different therapeutic antioxidant strategies either 
individually or in combination with chelating agent are indis-
pensable.  The  present  review  focuses  on  structural,  chemical 
and biological aspects of antioxidants particularly related to their 
chelating properties.
Introduction
Oxidation  is  a  chemical  reaction  involving  transfer  of  an 
electron from electron rich to electron deficient entity. The elec-
tron deficient molecule is termed an oxidizer or oxidizing agent. 
Heavy metals due to the presence of vacant d-orbital behave as 
potent oxidizing agents. Metals and metal compounds are natural 
constituents  of  all  ecosystems,  moving  between  biological  and   
non-biological system.1 Numerous studies have reported toxic and 
carcinogenic effects induced when humans and animals are exposed 
to certain metals especially arsenic,2 lead,3 cadmium,4 chromium5 
and  mercury.6  A  growing  amount  of  results  provide  evidence 
that  toxic  and  carcinogenic  metals  are  capable  of  interacting 
with nuclear proteins and deoxyribonucleic acid (DNA) causing 
oxidative  deterioration  of  biological  macromolecules.  Detailed 
studies in the past two decades have shown that metals like iron, 
cadmium, chromium, mercury, arsenic and lead possess the ability 
to produce reactive free radical species, which start chain reaction 
resulting in oxidation of lipid termed as lipid peroxidation, protein   
oxidation and oxidation of nucleic acid like DNA and ribonucleic 
acid (RNA).7 Deleterious free radical-mediated oxidations occur   
in aerobic organism as a result of normal oxygen metabolism.
An antioxidant is a substance capable of preventing or slowing 
the oxidation of other molecules. Generally, an antioxidant can 
protect against metal toxicity by trapping free radicals thus termi-
nating the chain reaction, by chelating metal ion and preventing 
the reaction with reactive oxygen species or by chelating metal 
and maintaining it in a redox state leading to its incompetency to 
reduce molecular oxygen. Substances which protect biomolecules 
from free radical-mediated damage both in vivo and in vitro fall 
under this category. Reactive oxygen species (ROS) and Reactive 
Nitrogen  Species  (RNS):  (1)  are  generated  during  irradiation 
by UV light, by X-rays and by gamma rays; (2) are products of 
metal-catalyzed reactions; (3) are present as pollutants in the atmo-
sphere; (4) are produced by neutrophils and macrophages during 
inflammation; (5) are by-products of mitochondria-catalyzed elec-
tron transport reactions and other mechanisms.8 ROS at higher 
concentration  are  important  mediators  of  damage  to  cell  cell 
structures, including lipids and membranes, proteins and nucleic 
acids (termed oxidative stress).9 The harmful effects of ROS are 
balanced by the antioxidant action of non-enzymatic antioxidants 
in addition to antioxidant enzymes.10
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This paper examines a discussion of the various protec-
tive pathways that may be provided by the antioxidant 
network against the deleterious action of free radicals.
Chemistry and Biochemistry of Free Radicals
Reactions of free radicals. Free radicals can be defined 
as  molecules  or  molecular  fragments  containing  one 
or  more  unpaired  electrons.11  Although  this  definition 
does not specify exactly, where the unpaired electron is 
present, still it is preferred because it allows us to classify 
most of the transition metal ions as free radicals and thus 
better understand the close interrelation between 
oxygen and reactive metal ions. Due to presence 
of this unpaired electron, these radicals confer a 
considerable degree of reactivity.
Figure 1 shows the generation of some of the 
reactive oxygen species. The hydroperoxyl radical 
formed above dissociates to give superoxide anion 
radical at physiological pH 7.4. Superoxide anion 
can  further  interact  with  other  molecules  to 
generate other ROS either directly or prevalently 
through enzyme- or metal-catalyzed processes (O2
•-). Superoxide 
ion is rapidly detoxified initially to hydrogen peroxide because of 
its dismutation reaction to form hydrogen peroxide and oxygen12 
and finally to water by Cu, Zn-SOD and/or Mn-SOD.
Significant amounts of hydrogen peroxide are formed in the 
mitochondria and this is enriched with antioxidants such as super-
oxide dismutase (SOD) and glutathione peroxidase (GPx) which 
minimizes the oxidative stress.13
Fe  (II)  can  participate  in  the  Fenton  reaction,  generating   
highly  reactive  hydroxyl  radical.  Thus  under  stress  conditions 
O2
•- facilitates OH• production from H2O2 by making Fe (II) 
available for the Fenton reaction. On the other hand the superoxide   
radical participates in the Haber-Weiss reaction which combines 
a Fenton reaction and the reduction of Fe (III) by superoxide, 
yielding Fe (II) and oxygen.
Metal Induced Oxidative Stress
Numerous  studies  have  focused  on  metal-induced  toxicity 
and carcinogenicity, emphasizing their role in the generation of 
reactive oxygen and nitrogen species in biological systems, and 
the significance of this therein. Metal-mediated formation of free 
radicals may cause various modifications to DNA bases as well as 
can enhance lipid peroxidation (Fig. 2).
Oxidative stress, a condition describing the production of oxygen 
radicals beyond a threshold for proper antioxidant   neutralization, 
has been implicated as a pathologic condition in several cellular 
disorders. Besides ROS, metal exposure can also affect the genera-
tion  of  RNS.  Nitric  oxide  (NO)  is  a  messenger  molecule  that 
plays  an  important  role  in  neurotransmission,  vasodilation  and 
immune response.14 NO also possesses toxic effects such as pro-
oxidant effects, genotoxicity and mutagenicity. Production of NO 
is catalyzed mainly by NO synthases, which consist of neuronal, 
endothelial and inducible forms.15
A number of metals have been long known in literature for 
their toxicity and carcinogenicity. Increased amounts of iron in the 
body poses enhanced risk of a variety of diseases including vascular 
disease, cancer and certain neurological conditions.16,17 Copper at 
high concentration is known to cause metastasis of cancer cells.18 
Cobalt(II) complexes are known to produce oxygen radicals which 
causes heart toxicity.19,20
Arsenic is one of the most toxic elements and produces a variety 
of  ROS  including  superoxide  (O2
•-),  singlet  oxygen  (1O2),  the 
peroxyl radical (ROO•), nitric oxide (NO•), hydrogen peroxide 
(H2O2), dimethylarsinic peroxyl radicals [(CH3)2AsOO•] and also 
the dimethylarsinic radical [(CH3)2As•].21-24 As(III) enhances the 
production of heme oxygenase, an indicator of oxidative stress in 
a variety of human and mammalian cell types25 and generates free 
radicals in livers of mice.26 The production of ROS by various 
arsenic metabolites was confirmed by animal experiments.27
Different mechanisms have been accounted for the toxicity of 
arsenic. Arsenic (III) compounds bind to sulfhydryl (-SH) groups 
and can inhibit various enzymes, including glutathione reductase 
while Arsenic (V) inhibits PDH28 activity thus causing impaired 
glucose metabolism.28,29
Studies have shown that lead causes oxidative stress by inducing 
the generation of reactive oxygen species (ROS) and weakening the 
antioxidant defence system of cells.30-32 Depletion of cells’ major 
sulfhydryl reserves e.g., δ-aminolevulinic acid dehydratase (ALAD) 
seems to be an important indirect mechanism for   oxidative stress 
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Figure 1. Redox reaction showing generation of various Reactive Oxygen Species 
(ROS).
Figure 2. Effects of ROS on DNA damage leading to its role in carcinogenesis.Antioxidants and metal toxicity
These enzymes are important for maintaining critical balance in 
the glutathione redox state. Malondialdehyde (MDA) levels were 
strongly correlated with lead concentration in the tissues of lead 
exposed rats.38 The concentration of thiobarbituric acid reactive 
substance  (TBARS),  which  is  a  reflection  of  endogenous  lipid 
oxidation level, gets increased on lead exposure. The interaction 
of lead with oxyhaemoglobin (oxyHb) has been suggested as an 
important source of superoxide radical formation in RBCs.
Also  studies  have  demonstrated  the  reactions  of  hydroxyl 
radicals which leads to abstraction of a hydrogen atom from the 
protein polypeptide backbone to form a carbon-centered radical, 
which  under  aerobic  conditions  reacts  readily  with  dioxygen 
to  form  peroxyl  radical.47  Metal-catalyzed  damage  to  proteins 
involves  oxidative  scission,  loss  of  histidine  residues,  bityrosine 
crosslink,  the  introduction  of  carbonyl  groups,  and  the  forma-
tion of protein-centered alkyl, R•, alkoxyl, RO• and alkylperoxyl, 
ROO•, radicals.48
Nomenclature and Classification of Antioxidants
Table 1 lists categories in which various antioxidants have been 
characterized based on their structure, occurrence and mode of 
action, solubility and kinetics.
Kinetically antioxidants can be classifieds into six categories as 
below:
(1)  Antioxidants  that  break  chains  by  reacting  with  peroxyl 
radicals having weak O-H or N-H bonds: phenol, napthol, hydro-
quinone, aromatic amines and aminophenols.
(2)  Antioxidants  that  break  chains  by  reacting  with  alkyl   
radicals: quinones, nitrones, iminoquinones.
(3)  Hydro  peroxide  decomposing  antioxidants:  sulphide,   
phosphide, thiophosphate.
(4) Metal deactivating antioxidants: diamines, hydroxyl acids 
and bifunctional compounds.
(5) Cyclic chain termination by antioxidants: aromatic amines, 
nitroxyl radical, variable valence metal compounds.
(6) Synergism of action of several antioxidants: phenol sulphide 
in which phenolic group reacts with peroxyl radical and sulphide 
group with hydro peroxide.
Antioxidants  as  chelating  agents  and  their  mechanism  of 
action.  Non-enzymatic  antioxidants49  as  well  as  antioxidant 
enzymes50 (Fig. 3) are known to counteract the effect of ROS and 
RNS. These antioxidants are known to diffuse free radicals leading 
to limited risk of oxidative stress. At cellular and molecular level 
they inactivate ROS and under specific low concentration inhibit 
or delay oxidative processes by interrupting the radical chain reac-
tion. Antioxidants also chelate the metal ions responsible for the 
generation of ROS as they have the potentials to work in both 
aqueous and/or membrane domains.
Chelation is the formation of a metal ion complex in which 
the metal ion is associated with a charged or uncharged electron 
donor  referred  to  as  ligand. The  ligand  may  be  monodenate, 
bidenate  or  multidenate,  that  is,  it  may  attach  or  co-ordinate 
using one or two or more donor atoms. Bidenate ligands form 
ring  structures  that  include  the  metal  ion  and  the  two-ligand 
atoms attached to the metal.51 Their efficacy depends not solely 
on their affinity for the metal of interest but also on their affinity 
that is induced by redox-inactive metals.33,34 Further, zinc which 
usually serves as a cofactor of many enzymes could be replaced 
by  lead,  thereby  making  the  enzyme  inactive.  The  increased 
lipid  peroxidation  and  inhibition  of  enzymes  responsible  to 
prevent such oxidative damage have demonstrated lead induced 
oxidative injury.35 Lead induced disruption of the pro-oxidant/
antioxidant balance could induce injury via oxidative damage to 
critical biomolecules. A significant decrease in the activity of tissue 
superoxide dismutase (SOD), a free radical scavenger and metal-
loenzymes  (zinc/copper)  on  lead  exposure  has  been  reported.36 
Catalase is an efficient decomposer of H2O2 and known to be 
susceptible to lead toxicity.31 Lead induced decrease in brain GPx 
activity may arise as a consequence of impaired functional groups 
such as glutathione (GSH) and NADPH or selenium mediated 
detoxification of toxic metals.37 Antioxidant enzyme glutathione 
S-transferase (GST) is known to provide protection against oxida-
tive  stress  and  the  inhibition  of  this  enzyme  on  lead  exposure 
might be due to the depletion in the status of tissue thiol moiety. 
Table 1    Alphabetical classification of antioxidants, 
their categories with few examples
Alphabetical  Categories of  Examples 
name  antioxidants
Antioxidant C  Carotenoids  β-carotene, Lycopene, Lutein
Antioxidant E  Enzymes  SOD, Catalase, GPx
Antioxidant G  Glutathione  Glutathione
Antioxidant H  Hormones  Melatonin, Oestrogen
Antioxidant L  Lipid associated  Ubiquinol-10, N-acetyl 
  chemicals  cysteine, lipoic acid
Antioxidant M  Minerals  Zinc, Selenium, Copper
Antioxidant P  Phenolics  Quercetin, Catechin
Antioxidant S  Saponines, Steroids  Cortisone, Estradiol, Estriol
Antioxidant V  Vitamins  α-tocopherol, Ascorbic acid
Figure 3. Enzymatic and non enzymatic classification of antioxidants with 
few.
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Non-enzymatic antioxidants. Vitamin C. Vitamin C (ascorbic 
acid) is a very important, and powerful, antioxidant that works 
in  aqueous  environments  of  the  body.  Vitamin  C  cooperates   
with Vitamin E to regenerate α-tocopherol55 from α-tocopherol 
radicals in membranes and lipoproteins.
Ascorbic acid, behaves as a vinylogous carboxylic acid, wherein 
the double bond (“vinyl”) transmits electron pairs between the 
hydroxyl and the carbonyl. Ascorbate acts as an antioxidant by 
being  available  for  energetically  favorable  oxidation.  Reactive 
oxygen  species  oxidize  (take  electrons  from)  ascorbate  first  to 
monodehydroascorbate and then dehydroascorbate. The reactive 
oxygen species are reduced to water, while the oxidized forms of 
ascorbate are relatively stable and unreactive, and do not cause 
cellular damage.
A schematic diagram (Fig. 4) below shows the various forms of 
ascorbic acid (Vitamin C) and its reaction with radicals (R•).56,57
Vitamin  C  scavenges  the  aqueous  reactive  oxygen  species   
(ROS) by very rapid electron transfer that inhibits lipid peroxida-
tion.58,59  Animal  studies  have  suggested  an  antagonistic  effect   
of ascorbic acid on lead absorption with its excellent chelating 
ability  towards  lead  which  is  in  good  comparison  to  standard 
chelator ethylenediamine tetra acetic acid (EDTA).60,61
Metal  chelation  studies  have  shown  that  chelation  of  Zn(II)   
and Mn(II) ions takes place via two—OH groups while, Cd(II) 
ion binds via the O-3 atom only while the Hg(II) ion interaction 
leads to the oxidation of the ascorbic acid in aqueous solution.62 
Vitamin C in plasma increases dose-dependently resistance to-lipid 
peroxidation, even in the presence of redox-active iron or copper 
and H2O2.63
for  endogenous  metals.  An  ideal  chelator  should  have  high   
solubility  in  water,  resistance  to  biotransformation,  ability  to 
reach site of metal storage, ability to retain chelating ability at 
the pH of body fluid and property of forming metal complexes   
that are less toxic than the free metal ion.
An ideal heavy metal chelator should be able to enter the cell 
easily,  chelate  the  heavy  metal  from  its  complex  with  metallo-
thionein or other proteins, and increase the excretion of the metal 
without its redistribution to other organs or tissues.52 Chelation 
therapy compromises with various side effects especially loss of 
essential elements. Chelating agents shows their binding affinity 
almost  for  all  positively  charged  ions. Thus  there  is  a  need  of   
safe and effective treatment against heavy metal toxicity. If any 
antioxidant satisfy above mentioned criteria of chelating agent it 
could serves as a chelating agent with less side effects.
Enzymatic antioxidants. One of the most effective intracellular 
enzymatic  antioxidants  is  superoxide  dismutase  (SOD)  which   
catalyzes  the  dismutation  of  O2
•-  to  O2  with  remarkably  high   
reaction  rates  by  successive  oxidation  and  reduction  of  the   
transition metal ion and to the less-reactive species H2O2.53
Catalase is an enzyme present in the cells of plants, animals and 
aerobic bacteria.54 Catalase is located in a cell organelle called the 
peroxisome. The enzyme very efficiently promotes the conversion 
of hydrogen peroxide to water and molecular oxygen.
Glutathione metabolism is one of the most essential of anti- 
oxidative  defence  mechanisms.  GPx  enzymes  in  presence  of   
tripeptide glutathione (GSH) add two electrons to reduce perox-
ides.54  GPx  decomposes  peroxides  to  water  (or  alcohol)  while 
simultaneously  oxidizing  GSH.  The  antioxidant  properties  of   
these  enzymes  allow  them  to  eliminate  peroxides  as  potential 
substrates for the Fenton reaction.
Figure 4. Conversion of ascorbic acid into different reduced forms at various pH indicating possible binding sites and free electrons responsible for their 
antioxidant and chelating property.Antioxidants and metal toxicity
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in reducing liver and kidney arsenic burden supports the view that 
vitamin C acts as detoxifying agent by forming a poorly ionized 
but soluble complex.32 Thus Vitamin C supplementation perspec-
tive,  though  observed  in  animal  model,  will  have  sustainable 
curative value among the already afflicted populations, neutral-
izing impact on freshly emerging metal poisoning scenario and   
possible  proactive  protection  to  those  potentially  susceptible  to 
heavy metal exposure.
Vitamin E. Vitamin E exists in eight different isomeric forms 
of two substructures tocopherol and tocotrienol (Fig. 5).69 Both 
structures are similar except the tocotrienol structure has double 
bonds on the isoprenoid units.
α-tocopherol is the most active form of vitamin E in humans 
and is a powerful biological antioxidant which is considered to be 
the major membrane bound antioxidant employed by the cell.70 
Its main antioxidant function is protection against lipid perox- 
idation.  During  the  antioxidant  reaction,  α-tocopherol  is   
converted  to  a  α-tocopherol  radical  by  the  donation  of  labile 
hydrogen  to  a  lipid  or  lipid  peroxyl  radical. The  α-tocopherol 
radical can thus be reduced to the original α-tocopherol form by 
Other studies indicate the ability of ascorbic acid to regulate 
factors that may influence gene expression, apoptosis and other 
cellular functions.64
However, studies in humans have shown some mixed results. 
In  a  study  with  78  male  workers,  38  received  vitamin  C  and   
38 were given placebo no effect of absorption or excretion of lead 
was found.65 An inverse relationship between serum vitamin C 
and blood lead levels was found in a cross-sectional study which 
analyzed 4,213 young and 15,365 adult Americans with mean 
blood  lead  level  of  2.5–3.5  mg/dl.66 Yet  another  study  among   
85  volunteers  drinking  lead-containing  drinking  water  showed 
small reductions in lead retention.67
A  consistent  protective  effect  of  Vitamin  C  has  also  been   
found in lung and colorectal cancer.68
In a recent published study, our group reported the remarkable 
effects of combined treatment of vitamin C and succimers like 
meso 2,3-dimercaptosuccinic acid (DMSA) or its monoisoamyl 
derivative (MiADMSA) on inhibited blood ALAD activity and 
in particular its beneficial effect in reducing the arsenic induced 
oxidative stress. Co-administration of vitamin C and MiADMSA 
Figure 5. Chemical structure of α-tocopherol and α-tocotrienol indicating isoprenoid units.Antioxidants and metal toxicity
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Oxidized glutathione GSSG is accumulated inside the cells and 
the ratio of GSH/GSSG is a good measure of oxidative stress of 
an organisms.87 Too high a concentration of oxidized glutathione 
GSSG may damage many enzymes oxidatively. GSSG can react 
with  protein  sulfhydryl  groups  to  produce  protein-glutathione 
mixed disulphide:
α-Lipoic acid. α-Lipoic Acid (1,2-dithione-3-pentanoic acid) 
is a sulfur-containing antioxidant with metal-chelating and anti-
glycation capabilities. Unlike many anti-oxidants, which are active 
only in lipid or aqueous phase, lipoic acid is active in both lipid 
and aqueous phases.88 Due to an asymmetric carbon having four 
different attached groups; lipoic acid exists as a pair of R- and S-. 
Naturally occurring lipoic acid is the R-form, but synthetic lipoic 
acid (known as alpha lipoic acid) is a racemic mixture of R-form 
and S-form in which R-enantiomer is more biologically active than 
the S-enantiomer.89
Lipoic  acid  is  readily  digested,  absorbed  and  transported 
to  tissues.  A  chronic/carcinogenic  study  in  rats  reported  that   
racemic lipoic acid was found to be non-carcinogenic and did not 
show any evidences of target organ toxicity. The No Observed 
Adverse Effect Level (NOAEL) was considered to be 60 mg/kg 
bw/day.90
LA is readily absorbed from diet and is rapidly converted to 
Dihydrolipoic  acid  (DHLA)  by  NADH  or  NADPH  in  most 
tissues (Fig. 6). Studies have demonstrated superior anti-oxidant 
activity of DHLA as compared to LA. Since DHLA can neutralize 
free radicals it is known to regenerate Vitamin C which is even 
better than GSH89 and Vitamin E from their oxidized forms.91,92
DHLA  possess  metal  chelating  properties  which  help  the 
body to get rid of accumulated ingested toxins.93 It has been 
shown  previously  that  oxidants  may  lead  to  cell  death  via 
lysosomal  rupture  and  that  this  latter  event  may  involve 
intralysosomal  iron  which  catalyzes  Fenton-type  chemistry 
and  resultant  peroxidative  damage  to  lysosomal  membranes.   
LA  stabilize  lysosomes  against  oxidative  stress,  probably  by 
chelating  intralysosomal  iron  and,  consequently,  preventing 
intralysosomal Fenton reactions.
Packer  et  al.92,94  proposed  a  hypothesis  of  LA  inducing 
cystine/cysteine uptake which examined the role of LA in stim- 
ulating GSH biosynthesis. In rats subjected to reperfusion injury 
following cerebral ischemia, LA restores brain GSH content and 
dramatically reduces the mortality rate from 78% to 26%.95
ascorbic  acid.71 Vitamin  E  perform  a 
unique  function  by  interrupting  free 
radical chain reactions via capturing the 
free radical. The free hydroxyl group on 
the aromatic ring is responsible for the 
antioxidant  properties.  The  hydrogen 
from this group is donated to the free 
radical,  resulting  in  a  relatively  stable 
free radical form of the vitamin.
The  antioxidant  function  of  this 
micronutrient  enhances  immunity  by 
maintaining the functional and struc-
tural  integrity  of  important  immune 
cells.72  Vitamin  E  has  the  ability  to  prevent  cell  injury  by   
maintaining the sulfhydryl groups of membrane proteins and by 
quenching free radicals.73
Vitamin  E  has  been  reported  to  protect  against  arsenic 
toxicity.74-76  Protective  value  of  vitamin  E  in  arsenic  induced 
toxicity  could  be  attributed  mainly  to  its  antioxidant  property 
or its location in the cell membrane and its ability to stabilize 
membrane  by  interacting  with  fatty  acid  chain.77 We  reported 
increased antioxidant enzymes activities, and GSH concentration 
and decreased lipid per oxidation in animals co-administered with 
arsenic and vitamin E. Vitamin E may preserve cell membrane 
function including ion transport and membrane fluidity. It may 
also  prevent  the  release  of  Fe2+  and  Mg2+  from  their  binding 
proteins, potentially decreasing the rate of lipid per oxidation.78
Our  group  has  also  reported  beneficial  effects  of  vitamins 
supplementation during lead intoxication. Intramuscular adminis-
tration of vitamin E prevented inhibition of blood ALAD activity, 
elevation of urinary ALA excretion and was effective in reducing 
the lead induced altered biogenic amines levels in brain during 
the  concomitant  exposure  lead.79  Vitamin  E  supplementation 
during concomitant lead exposure also prevented lead deposition 
in liver and blood. Some of the protective effects of vitamin E also 
emerge directly from its antioxidant property and some through its 
influence on the drug metabolising enzyme system.80,81 We also 
reported that administration of vitamin E when given in combi-
nation  with  meso  2,3-dimercaptosuccinic  acid  (DMSA)  or  its 
monoisoamyl derivative (MiADMSA) produced profound recov-
eries in sub-chronically lead exposed rat.82 Although, the group 
suggest that vitamin C was better in providing clinical recoveries 
and Vitamin E was equally efficient in decreasing the lead burden 
from the tissues.
Studies have also shown that vitamin E reduces the incidence of 
coloretal cancer by initiating the apoptosis of cancer cells.83,84
Glutathione.  The  major  thiol  antioxidant  is  the  tripeptide, 
glutathione.  Glutathione  (GSH)  is  a  multifunctional  intracel-
lular  non-enzymatic  antioxidant  which  is  considered  to  be  the 
major thiol-disulphide redox buffer of the cell.85 Generally, the   
antioxidant capacity of thiol compounds is due to the sulphur 
atom which can easily accommodate the loss of a single electron.86 
The reaction of glutathione with the radical R• as well as combina-
tion with another thiol radical is shown in:
Figure 6. Oxidized and reduced form of lipoic acid showing presence of thiol groups as the possible 
metal chelating sites.Antioxidants and metal toxicity
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Thus the possible mechanisms for the protecting effects of LA 
against oxidative stress may be as follows: (a) LA can be reduced to 
dihydrolipoic acid by NADH, (b) DHLA is a strong antioxidant 
to scavenge excess oxidants, and recycle other antioxidants such 
as  vitamin  E,  C  and  glutathione,  (c)  DHLA  chelate  metals  to   
prevent free radical generation92,94,108,109 thus to diminish oxidant 
attacks  on  bio-macromolecules,  (d)  LA  is  the  key  co-factor  of 
pyruvate  dehydrogenase  and  alphaketoglutaric  dehydrogenase 
the enzymes sensitive to oxidative stress, (e) supplementation of 
sufficient LA helps to fully stimulate activities of enzymes, thereby 
promoting and ameliorating oxidative phosphorylation and mito-
chondrial respiration110 and (f) LA can promote the antioxidant 
defense  by  inducing  phase  two  enzymes,  such  as  glutathione 
synthetase to elevate antioxidant GSH.111,112
Lipoic acid (LA) regenerates GSH from GSSG and dihydroli-
poic acid (DHLA) recycles ascorbic acid (AA) and dihydroascorbic 
acid (DHAA). DHLA restores vitamin E (VE) also.
LA satisfies two criteria to be a chelating agent i.e., absorption 
into the intracellular environment and complexing metals previ-
ously bound to other sulfhydryl proteins. Both LA and DHLA 
can chelate heavy metals, but the R-form is more effective for 
chelation.109 LA is most effective in chelating Cu2+, Zn2+ and 
Pb2+,  but  cannot  chelate  Fe3+  while  DHLA  forms  complexes 
with Cu2+, Zn2+, Pb2+, Hg2+ and Fe3+ that are poorly soluble in 
water. Although DHLA chelates Fe3+, it can also reduce Fe3+ to 
Fe2+ which shows its pro-oxidant efficacy. In so far as most iron 
is tightly bound to ferritin protein, DHLA may have the capacity 
to remove bound iron from ferritin. DHLA chelation of iron and 
copper in the brain may reduce free-radical damage contributing 
to  Alzheimer’s  disease.113  Small  amounts  of  cadmium  (Cd2+) 
can cause significant lipid peroxidation in the brain, which can 
be prevented by lipoic acid.114 Metal chelation by lipoic acid is 
presented in Figure 7.
LA  in  unbound  form  is  chemically  able  to  trap  circulating 
heavy metals, thus preventing cellular damage caused by metal 
toxicity.114 LA is lipophilic and is able to penetrate cell membranes 
and reach high intracellular concentrations within 30 seconds of 
its administration. Oral doses of 10 mg/kg LA in rats reaches peak 
levels  in  the  cerebral  cortex,  spinal  cord  and  peripheral  nerves 
within 30 minutes of administration and studies of chronic daily 
dosing conclude that LA reaches all areas of the central nervous 
system (CNS) and peripheral nervous system thus decreasing lipid 
peroxidation  in  brain  and  sciatic  nerve  tissue.94  Shila  et  al.115 
reported reduced arsenic concentration in brain tissue of animals 
supplemented with arsenic and LA. Lipoic acid might also have 
the capability to interfere with the absorption of arsenic. Beneficial 
role of LA against lead116 and GaAs100 toxicity in terms of lead 
and arsenic chelation form blood and soft tissues have also been 
reported.
N-acetylcysteine.  N-acetyl-L-cysteine  (NAC),  is  a  thiol-
containing  anti-oxidant  that  has  been  used  to  mitigate  various 
conditions  of  oxidative  stress.  It  reduces  liver  injury  caused  by 
paracetamol over dosage in human116 and attenuates liver injury 
and prevents liver and plasma GSH depletion in mice.117 Its anti-
oxidant action is believed to originate from its ability to stimulate 
GSH  synthesis,  therefore  maintaining  intracellular  GSH  levels   
LA has been reported to be effective in reducing the amount of 
OH• generated by Fenton type reactions and also a scavenger of 
peroxide and O2
•-.96 Sadi et al.97 proposed the increase in level of 
SOD and catalase after incubating with LA in diabetic rats towards 
normal value. Antioxidant effects of LA is based on their interac-
tions with peroxyl radicals, which are essential for the initiation 
of lipid peroxidation; and ascorbyl radicals of vitamin C. DHLA,   
can recycle ascorbyl radicals and reduce dehydroascorbate gener-
ated in the course of ascorbate oxidation by radicals. Therefore, 
DHLA may act as a strong chain-breaking antioxidant and may 
enhance the antioxidant potency of other antioxidants like vitamin 
C in both the aqueous and in hydrophobic membrane phase.98   
In addition to its antioxidant properties, LA can be neuroprotec-
tive in vivo through suppression of glial reactivity.99 Since chronic 
reactive gliosis exacerbates diabetic neuropathy, the administration 
of LA can prevent neuropathy by reducing both oxidative stress 
and glial hyperactivity.99 Bhatt et al.100 have reported antioxidant 
potential (redox potential of LA/DHLA -320 mV) and greater 
efficacy of LA over captopril and quercetin against gallium arsenide 
(GaAs) induced oxidative stress in rats.
LA has long been known as an essential cofactor for mitochon-
drial bio-energetic enzymes. Various in vitro and in vivo studies 
suggest that LA also acts as a powerful micronutrient with diverse 
pharmacologic  and  antioxidant  properties.  Pharmacologically, 
LA improves glycemic control, polyneuropathies associated with 
diabetes mellitus, and effectively mitigates toxicities associated with 
heavy metal poisoning. As an antioxidant, LA directly terminates 
free radicals, chelates transition metal ions (e.g., iron and copper), 
increases cytosolic glutathione and vitamin C levels and prevents 
toxicities associated with their loss. These diverse actions suggest 
that  LA  acts  by  multiple mechanisms  both  physiologically and 
pharmacologically.101 The relatively good scavenging activity of 
lipoic acid is due to the strained conformation of the 5-membered 
ring in the intramolecular disulfide.102
Exogenous administration of LA has been found to have thera-
peutic potential in neurodegenerative disorders also. LA can also 
cross the blood-brain barrier103 and is taken up by all areas of the 
central  and  peripheral  nervous  system.  Lipid  peroxides  (LPO) 
are the presumptive markers of free radical-associated oxidative 
stress.104-106 Free radical attack on poly unsaturated fatty acids 
(PUFA) in the biological system is thought to produce a sequence 
of reactions, which lead to the formation of both conjugated dienes 
and lipid hydroperoxides.107
Figure 7. Reduced form of lipoic acid showing metal chelation at thiol 
groups (M = Cu2+, Zn2+, Cd2+, Pb2+, Hg2+ and Fe3+).Antioxidants and metal toxicity
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NAC pretreated animal effectively detoxifies or removes arsenic via   
GSH  dependent  pathway.  It  is  probably  due  to  an  enhanced 
ability  to  maintain  GSH  homeostasis  during  exposure  to  toxic 
electrophiles generated by arsenic as well as its rapid elimination/
excretion from the body.
Besides  arsenic  NAC  shows  chelating  property  against  lead 
also.126 One of the first report by Pande et al.127 suggested that 
NAC could be used both as preventive as well as therapeutic agent 
along with MiADMSA/DMSA in the prevention or treatment of 
lead intoxication in rats. They reported that co-administration of 
NAC with DMSA reversed the altered ALAD and TBARS levels, 
increased the GSH level and decreased the lead level from blood 
and soft tissues. They proposed that NAC administration have a 
beneficial role, which is independent of chelation. However, no 
change in blood glutathione levels in lead exposed rats, as well 
as in NAC administered rats, provides a more complex theory 
that  either  all  of  the  free  sulfhydryl  group  may  be  utilized  in 
complexing  circulatory  lead  or  perhaps  the  lead  concentration 
in  blood  following  exposure  could  not  reach  alarmingly  high 
to  influence  blood  GSH.128,129  A  recent  report  suggested  that 
co-administration of NAC along with DMSA in sub-chronically 
lead exposed rats reduced oxidative stress significantly by lowering 
the TBARS and GSSG level along with decreased lead burden 
from soft tissues especially brain.130
Beside the antioxidant potential NAC, has also shown to have 
various  other  important  functions,  like  the  antimutagenic  and 
and  scavenging  ROS.118,119  NAC,  is  rapidly  deacetylated  to 
cysteine  and  thus  may  increase  GSH  levels  by  providing  the 
substrate for the rate limiting step in GSH synthesis.120 Structure 
of NAC along with possible chelating sites is presented in Figure 
8.
NAC  is  known  to  have  metal-chelating  properties  and  has 
been used in several clinical conditions.121 Thiol groups present 
in NAC act to reduce free radical and provide chelating site for 
metals. Thus, NAC has a strong ability to restore the impaired pro-
oxidant/antioxidant balance in metal poisoning. NAC can cross 
the cell membrane therefore provide intracellular effects. Martin 
et al.122 reported a better response of acute arsenic symptoms to 
intravenous NAC than intramuscular 2,3-dimercapto-1-propanol. 
We recently provided evidence of a novel therapeutic combina-
tion to achieve greater effectiveness in chelation treatment against 
chronic arsenic intoxication in rats.123 Combined administration 
of NAC and Succimer post arsenic exposure led to a significant 
turnover in the variables indicative of oxidative stress and removal 
of toxic metal (arsenic) from the soft organs.123 This combination 
provided  a  more  pronounced  reduction  in  the  arsenic  induced 
oxidative stress in liver and brain beside a rapid depletion of soft 
tissue arsenic burden compared to treatment with DMSA or NAC 
alone. The major hypothesis behind this new protocol was that, 
(1) NAC beside a strong antioxidant is a thiol compound and 
thus, will provide an additional site for metal chelation; and (2) 
NAC, because of its ability to restore the impaired pro-oxidant: 
antioxidant balance, will accelerate clinical or biochemical recov-
eries. Modi et al.124 proposed protective efficacy of Zn and NAC 
co-administration against arsenic induced oxidative stress. Santra 
et al.125 reported that in arsenic-induced liver cell injury in mice 
is associated with induction of oxidative stress, the perturbations 
in the mitochondrial redox state and arsenic-induced apoptosis of 
hepatocytes and all these changes were reduced in intensity and/or 
modified by pretreatment with NAC. They showed that on treat-
ment with NAC could replete cellular stores of the tripeptide GSH 
and  are  an  effective  intervention  against  oxidative  stress  devel-
oped due to arsenic exposure. They also proposed that observed 
hepatoprotection  provided  by  NAC  could  because  the  liver  of 
Figure 8. Structure of N-acetyl cysteine (NAC) depicting (1) two chelating sites (thiol and hydroxyl) and (2) deacetylation responsible for its antioxidant 
potential due to the generation of glutathione.
Figure 9. Structure of taurine showing sulfonate group as an electrophilic 
and amide group as a nucleophilic center responsible for it chelating and 
antioxidant properties, respectively.Antioxidants and metal toxicity
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this in part might explain the significant elimination of lead from 
the brain tissues. Flora et al.142 have reported that taurine when 
administered along with MiADMSA could significantly reduce the   
arsenic concentration in blood, liver and kidneys. This suggests 
that the antioxidant capacity of taurine becomes most effective 
when it is administered along with the thiol chelators or taurine 
might be facilitating the entry of chelator to the intracellular sites 
thereby reducing arsenic concentration.
Carotenoids. Carotenoids (Car) are pigments that are found 
in  plants  and  microorganisms.  Various  studies  have  indicated 
that carotenoids may prevent or inhibit certain types of cancer,   
arthrosclerosis,  age-related  muscular  degeneration  and  other 
diseases.
The  antioxidant  activity  of  carotenoids  arises  primarily  as 
a  consequence  of  the  ability  of  the  conjugated  double-bonded 
structure  to  delocalize  unpaired  electrons.154  This  is  primarily 
responsible  for  the  excellent  ability  of  α-carotene  to  physically 
quench singlet oxygen without degradation, and for the chemical 
reactivity  of  α-carotene  with  free  radicals  such  as  the  peroxyl 
(ROO•), hydroxyl (•OH) and superoxide radicals (O2
•-). At suffi-
ciently high concentrations, carotenoids can protect lipids from 
peroxidative damage.155 Carotenoids have antiproliferative effect 
on various cancer cell lines; lycopene has been shown to inhibit   
cell  cycle  progression  in  breast,  lung  and  prostate  cell  lines. 
β-Carotene  has  been  shown  to  inhibit  the  expression  of  anti-
apoptotic protein Bcl-2 in cancer cells, reducing thus growth of 
cancer cells.156
Flavonoids.  Polyphenolic  compounds  constitute  one  of  the 
most  commonly  occurring  and  ubiquitous  groups  of  plant 
metabolites and represent an integral part of human.157-159 Their 
common structural feature is the diphenylpropane moiety, which 
consists of two aromatic rings linked through three carbon atoms 
that together usually form an oxygenated heterocycle. Phenolic 
compounds acting as antioxidants may function as terminators of 
free radical chains and as chelators of redox-active metal ions that 
are capable of catalyzing lipid peroxidation.159
One of the most actively studied properties of flavonoids is their 
protection against oxidative stress.158,160 For example, flavonoids 
are  ideal  scavengers  of  peroxyl  radicals  due  to  their  favorable 
reduction potentials relative to alkyl peroxyl radicals and thus, 
in principle, they are effective inhibitors of lipid peroxidation.160 
Of  particular  importance  is  the  hydrogen  (electron)  donating 
ability of a flavonoid molecule which acts to scavenge a reactive 
radical species, and is primarily associated with the presence of 
a B-ring catechol group (dihydroxylated B-ring). One important 
structural feature which is partly responsible for the antioxidant 
properties of flavonoids involves the presence of 2,3 unsaturation 
in conjugation with a 4-oxo group in the C-ring. In addition, the 
presence of functional groups involving both hydroxyl groups of   
ring-B  and  the  5-hydroxy  group  of  ring-A  are  all  important 
contributors in the ability of flavonoids to chelate redox-active 
metals and thus prevent catalytic breakdown of hydrogen peroxide 
(Fenton chemistry).
Quercetin.  Quercetin  is  one  of  the  most  frequently  studied 
bioflavonoid. Flavonoids are polyphenolic compounds possessing 
15 carbon atoms, two benzene rings joined by a linear three carbon 
anticarcinogenic, in vitro and in vivo. NAC has been demonstrated 
to inhibit the in vivo DNA adduct formation after administration 
of aminothiorene or benzopyrene exposure. NAC is also known 
to  protect  certain  enzymes  involved  in  DNA  replication  and 
repair.131,132
Taurine. Taurine (2-aminoethanesulfonic acid) is a nonessen-
tial sulfur-containing amino acid that functions with glycine and 
gamma-amino butyric acid as a neuro inhibitory transmitter.133 
The zwitterionic nature of taurine gives it high water solubility and 
low lipophilicity. Consequently compared with carboxylic amino 
acids, diffusion through lipo-philic membranes is slow for taurine. 
It acts as a metabolic transmitter and additionally has a detoxi-
fying  effect  and  strengthens  cardiac  contractility.  It  crosses  the 
blood brain barrier134,135 and has been implicated in a wide array 
of physiological phenomena including long term potentiation in 
the  striatum/hippocampus136  membrane  stablization137  calcium 
homeostasis138 and protection against glutamate excitotoxicity.139 
It  also  acts  as  an  antioxidant  and  protects  against  toxicity  of 
various heavy metals including arsenic, lead and cadmium.140-142 
Zahorodnyi and Nebesna143 established that the sulfonate group 
of taurine is a electrophilic center and amide group is a nucleo-
philic center (Fig. 9). The biggest value of electrostatic potential 
is located around sulfonate group. This big value of energy of low 
occupied molecular orbital of taurine gives grounds to consider 
this substance as a reducing reagent and explains its antioxidant 
properties.
Low levels of taurine have been associated with retinal degen-
eration,  growth  retardation  and  cardiomyopathy.144,145 Taurine 
has also been used clinically in the treatment of cardiovascular 
diseases, hypercholesterolemia, seizure disorders, ocular disorders, 
diabetes,  Alzheimer’s  disease,  hepatic  disorders,  cystic  fibrosis 
and alcoholism.146,147 Taurine can act as a direct antioxidant by 
scavenging reactive oxygen species or as an indirect antioxidant 
by preventing changes in membrane permeability due to oxidant 
injury.148-150 As a direct antioxidant, taurine is able to quench and 
detoxify some reactive intermediates such as hypochlorous acid 
generated  by  myeloperoxidase149  nitric  oxide148  and  H2O2.151 
On  the  other  hand,  as  an  indirect  antioxidant,  taurine  protect 
cells via intercalating into the membrane and stabilizing it.152 The 
membrane protective effects of taurine are suggested to be related 
to an action on permeability to ions and water.150
In  the  studies  conducted  by  Gurer  and  Ercal80  taurine  was 
shown to have beneficial effects in lead induced oxidative stress 
in Chinese Hamster Ovary (CHO) cells and rats. An antioxidant 
mechanisms rather than a chelating activity, seems to underlie this 
observed effects of taurine against lead-induced oxidative stress. 
We recently described the dose dependent effect of taurine, either 
alone or in combination with meso 2,3-dimercaptosuccinic acid 
(DMSA) in the treatment of sub-chronic lead intoxication in male 
rats.153 The results suggested beneficial role of taurine when admin-
istered along-with DMSA in providing effective reversal of number 
of lead sensitive biochemical variables in general, and parameters of 
oxidative stress in particular, compared to their individual effects. 
We  noted  significant  effect  of  taurine  when  co-administered 
with DMSA, in depleting blood and brain lead. It is known that 
highest concentration of taurine is in brain and heart. Perhaps Antioxidants and metal toxicity
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The propensity of a flavonoid to inhibit free-radical mediated 
events is governed by its chemical structure. Multiple hydroxyl 
groups  confer  upon  the  molecule  substantial  antioxidant,  and 
chelating  ability.  A  double  bond  and  carbonyl  function  in  the 
heterocycle or polymerization of the nuclear structure increases 
activity by affording a more stable flavonoid radical through conju-
gation and electron delocalization.173 Quercetin has the ability to 
form semiquinone and quinine type compounds by undergoing 
one or two electron oxidation respectively. In this form it is able to 
chelate metal ions and form five member chelating ring.174
Its  anti-radical  property  is  directed  to  scavenge  OH.  and 
the  superoxide  anion,  highly  reactive  species  implicated  in  the 
initiation of lipid peroxidation. On the other hand, quercetin as 
a phenolic compound, may act as a metal-chelating agent, and in 
fact, it belongs to a special class of bidentate O,O-coordinating 
ligands which is capable of undergoing both one or two electron 
oxidations, forming semiquinone and quinone type compounds 
respectively.175-177  There  are  many  reports  in  the  literature  of 
quercetin-metal complexes but most of these are solution studies 
in which no compounds were isolated. Bravo and Anacona,178 
have reported coordination site at quercetin and its bonding prop-
erties on the basis of spectroscopic analysis. They proposed that 
carbonyl oxygen atom does not participate in coordination to the 
metal ions and coordination proceeds through the ortho-phenolic 
groups located on the quercetin B ring (Fig. 10). Their ability to 
form  complexes  with  some  p-,  d-  and  f-electron  metals  makes 
them  interesting  analytical  reagents.  Quercetin  possesses  three 
possible chelating sites in competition: the 3-hydroxychromone, 
the  5-hydroxychromone  and  the  3',4'-dihydroxyl  groups  and 
is most widely used for detection of metals bound to flavonoid 
ligands  owing  to  their  highly  sensitive  molecular  fluorescence   
properties. Analytical procedures have been developed for Al, Cr, 
W, Zr, Ti, Fe, Mo, Zr, Hf, Ge, Ru, Pd, Os, Pt and Au.179
Quercetin  contains  numerous  double  bonds  and  hydroxyl 
groups that can donate electrons through resonance to stabilize the 
free radicals.180 The radical scavenging properties associated with 
the structure of quercetin defend against oxidative stress and in 
doing so, reduce heart disease, prevent cancer, and slow the aging 
atom chain (structure A). The chemical structure of flavonoids   
are based on a C15 skeleton with a chromane ring bearing a second 
aromatic ring B in position 2, 3 or 4 (structure B).
    A      B
Various subgroups of flavonoids are classified according to the 
substitution patterns of ring C. Both the oxidation state of the 
heterocyclic ring and the position of ring B are important in the 
classification.
The flavonol quercetin (3',3,4',5,7-pentahydroxyflavone) is one 
of the most abundant dietary flavonoids.161 It is found in many 
fruits and vegetables, as well as olive oil, red wine and tea.162,163 
A recent report indicates that blood plasma concentrations may 
reach  in  excess  of  20  μM  quercetin  and  quercetin  metabolites 
in  response  to  quercetin-rich  diets.164  Quercetin  was  found  to 
scavenge  free  radicals  and  reduce  the  oxidability  and  cytotoxic 
effects of low density lipoproteins.165,166 High consumption of 
flavonoid rich food has therefore also been linked to a reduced 
incidence of cancers at various sites.167 Quercetin have multiple 
biological,  pharmacological  and  medicinal  properties  including 
anti-inflammatory,  anti-allergic,  antiviral,  antithrombotic,  anti-
mutagenic,  antineoplastic  and  cytoprotective  effects.168  Various 
epidemiological  and  dietary  studies  suggest  that  quercetin  may 
play a useful role in preventing neurodegeneration, especially age-
related  cognitive,  motor  and  mood  decline  and  protect  against 
oxidative stress as well as cerebral ischemic injuries.169 Quercetin 
induces growth inhibition and cell death in a variety of cancer cells 
including glioma cells.170,171 Quercetin has been reported to have 
both protective and detrimental effects.172 The precise molecular 
mechanism of quercetin action is poorly understood. Quercetin 
might exert the protective effect against the cell death associated 
with generation of ROS.
Figure 10. Structure of quercetin showing coordination through the ortho-phenolic groups located on the B ring.Antioxidants and metal toxicity
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ring o-dihydroxyl groups, the 4-oxo group in conjugation with 
the 2,3-alkene, and the 3- and 5-hydroxyl groups.181 The func-
tional groups can donate electrons to the rings, which increase the 
number of resonance forms available in addition to those created 
by the benzene structure.187
Many flavonoids are bound to sugars in their natural state, the 
O-glycoside form, where glycosylation can occur at any hydroxyl 
group to yield a sugar. The most common quercetin glycosides 
have a sugar group at the 3-position, such as quercetin-3-O-β-
glucoside shown in Figure 11.
Glycosylated structures are most common in nature, not the 
parent  compound.188  Most  studies  assessing  the  antioxidant 
properties of quercetin utilize the parent form; however, analysis 
of  plasma  after  quercetin  consumption  indicates  that  quercetin 
metabolites,  like  glucuronide  (quercetin-3-O-β-D-glucuronide), 
are the primary compounds circulating in the blood.189
Quercetin can also protect against the more obvious 
environmental  causes  of  free  radicals,  such  as  smoking. 
Cigarette tar is a source of free radicals, which has been 
found  to  damage  erythrocyte  membranes.  Begum  and 
Terao,190  found  that  the  quercetin  and  its  conjugate 
metabolites (quercetin-3-O-β-glucuronide and quercetin-
3-O-β-glucoside)  could  protect  erythrocytes  from  the 
membranous  damage  that  is  caused  by  smoking.  The 
control used in the study was flavone, which has the basic 
structure  of  quercetin  but  no  hydroxyl  groups,  and  it 
had no effect on the erythrocytes. This indicated that the 
hydroxyl groups are important to the antioxidant proper-
ties of quercetin.
Quercetin  is  also  reported  to  prevent  apoptosis  in 
several  cells  such  as  fibroblasts,  cardiomyoblasts,  and 
epithelial cells.191,192 Quercetin was found to attenuate 
oxidative damage induced by arsenic by restoring GSH 
contents and ROS levels and reducing TBARS levels.193 
Quercetin  has  also  been  reported  to  increase  metallothionein 
expression and prevent cadmium-induced Nephrotoxicity.194  In 
spite  of  these  positive  effects  of  quercetin,  there  have  been  a 
number of conflicting report about quercetin like it acts as a pro-
oxidant or has some moderate toxicity195 however, it is widely 
accepted that the beneficial effects of quercetin are due mainly to 
its antioxidant properties and also due to regulation of signaling 
pathway. Quercetin administration was also found to be associ-
ated with reduced condition of oxidative stress induced by GaAs 
exposure.100 Mishra et al.193 have also reported that the combined 
treatment with quercetin and MiADMSA was not only able to 
chelate arsenic from the cell but also ameliorate oxidant levels, i.e., 
abatement of toxic effects of arsenic.
Garlic. Garlic (Allium sativum L., family Liliaceae), called Lasan 
in India, is a medicinal plant which has been used for thousands 
of years in Indian Ayurvedic medicine. It is also used with spices 
to give a special flavor and fragnance to the food. Garlic contains a 
number of organosulfur compounds which are widely believed to 
be the active agents.194 The major medicinal compound obtained 
from garlic is Allicin, a powerful anti-biotic and anti-fungal agent. 
Precursor of Allicin is alliin which on decomposition with pyruvic 
acid and ammonia in the presence of garlic constitutional enzyme 
processes in cells responsible for degenerative diseases.181 Quercetin 
interfere by reacting with the radicals formed in the process of   
lipid  peroxidation.181-183  Quercetin  does  not  only  stop  the   
propagation of lipid peroxidation, but also increases glutathione 
(GSH) levels.184 GSH can convert hydrogen peroxide to oxygen 
and water, preventing the formation of free radicals.184 Oxidative 
stress can cause cell death by means of prolonged elevations of 
intracellular Ca2+ concentrations.185 Quercetin can protect cells 
suffering  oxidative  stress  and  thus  prevent  Ca2+-dependent  cell 
death.185
The  oxidation  of  low-density  lipoproteins  (LDL)  can  result 
in the formation of atherosclerotic plaques, leading to cardiovas-
cular  disease.181  Quercetin  has  displayed  the  ability  to  prevent 
the oxidation of LDL by scavenging free radicals and chelating 
transition metal ions. Graf and co-workers found a 21% reduction 
in cardiovascular disease mortality when the intake of quercetin 
was greater than 4 mg/day.186 Quercetin when reacts with a free 
radical, it donates a proton and becomes a radical itself, but the 
resulting unpaired electron is delocalized by resonance, making 
the quercetin radical too low in energy to be reactive.187 Three 
structural groups aid in quercetin’s ability to maintain its stability 
and act as an antioxidant when reacting with free radicals: the B 
Figure  11.  Structure  of  Quercetin-3-O-β-glucoside,  a  naturally  occuring 
predominat form of Glycosylated Quercetin.
Figure 12. Structures of major constituents of garlic depicting thiol and amino moi-
eties (the possible sites for metal chelation) along with the ketonic, sulphonic and 
hydroxyl groups (responsible for their antioxidant activity).Antioxidants and metal toxicity
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of cancer cells of murine and human origin. Allicin induced the 
formation of apoptotic bodies, nuclear condensation and a typical 
DNA ladder in cancer cells along with activation of caspases-3, -8 
and -9 and cleavage of poly(ADP-ribose) polymerase.213 Horie et 
al.214 demonstrated that AGE prevents the formation of thiobarbi-
turic acid-reactive substances during lipid peroxidation of rat liver 
microsomes. Among a variety of organosulfur compounds, SAC and 
S-allylmercaptocysteine (SAMC), major organosulfur compounds 
found in AGE, showed radical scavenging activity indicating that 
these compounds may play an important role in the antioxidative 
activity of AGE. These results suggest that the antioxidant effect of 
AGE may be due to its modulation of the glutathione redox cycle 
and SOD activity in vascular endothelial cells.
Sanapati et al.215 reported the prophylactic efficacy of garlic 
against lead and found that aqueous extract of garlic have ability 
to reduce lead burden from soft tissues. Choudhury et al.216,217 
reported co-administration of garlic extract is able to reduce the 
clasotogenic  effects  of  sodium  arsenite.  Apart  from  the  benefi-
cial role of garlic extract in arsenic induced oxidative stress they 
suggested the critical role of p53 and heat shock proteins. Recently 
Flora et al.218 reported that concomitant administration of garlic 
extract reduced tissue arsenic burden as well as increased urinary 
arsenic excretion. This phenomenon could be attributed to the 
thiosulphur components present in the garlic extract which may 
act as Lewis acids and interact with Lewis base (arsenic) to form 
stable  components.219,220  Chowdhury  et  al.221  suggested  that 
diverse  components  of  aqueous  garlic  extracts  like  allicin  also 
participate in possible chelation of arsenic. These authors suggested 
that  sulphur  bearing  components  of  aqueous  garlic  extract  are 
lipophilic and hence can permeate freely through phospholipids 
membrane.221,222
Conclusion
This  review  provides  an  insight  on  the  beneficial  effects  of 
different antioxidants in preventing arsenic or lead body burden 
and oxidative stress. The main structural features in antioxidants 
are the presence of -SH/-OH group either in the parent molecule 
or in their reduced form. It suggest that if an antioxidant molecule 
is able to provide free electron either in the form of a negative 
charge or in the form of a lone pair of electrons it may provide a 
chelating site for toxic metal. Besides, providing beneficial effects 
in eliminating heavy metal body burden and thereby reversing the 
altered biochemical variables these antioxidants could be useful in 
enhancing endogenous antioxidant levels. These antioxidants may 
also be supplemented during chelation therapy with a thiol chelator 
to get optimum therapeutic effects with fewer side effects.223,224
Acknowledgements
Author thanks Dr. R. Vijayaraghavan, Director of the establish-
ment for his support and Dr. Abhishek Yadav for his help during 
the preparation of this manuscript.
References
  1.  Bargagli R. Trace metals in Antarctica related to climate change and increasing human 
impact. Rev Environ Contam Toxicol 2000; 166:129-73.
  2.  Mishra D, Mehta A, Flora SJS. Reversal of hepatic apoptosis with combined administra-
tion of DMSA and its analogues in guinea pigs: role of glutathione and linked enzymes. 
Chem Res Toxicol 2008; 21:400-7.
alliinase gives Allicin. Whenever any part of the garlic is damaged, 
Allicin is formed which has the characteristic odor of garlic.
The  major  sulfur-containing  compounds  in  intact  garlic  are 
γ-glutamyl-S-allyl-L-cysteines  and  S-allyl-L-cysteine  sulfoxides 
(alliin). Both are abundant as sulfur compounds, and alliin is the 
primary  odorless,  sulfur-containing  amino  acid,  a  precursor  of 
Allicin, methiin, (+)-S-(trans-1-propenyl)-L-cysteine sulfoxide, and 
cycloalliin.195 These sulfoxides, except cyloalliin, are converted into 
thiosulfinates through enzyme reactions when raw garlic is cut or 
crushed. Besides this, a number of other antibiotic principles have 
also been isolated, namely, methyl-allyl thiosulfinates, 1-propenyl 
allyl thiosulfinate, L-glutamyl-S-alkyl-L-cysteine, S-allyl mercap-
tocysteine,  diallyl  disulfide,  -trisufide,  allyl  methyl  trisulfide, 
-disulfide, diallyl tetra sulfide, allyl methyl tetra sulfide, Dimethyl 
trisulfide,  Diallyl  sulfide,  2-vinyl-4-H-1,3-dithiin,  3-vinyl-4-H-
1,2-dithiin, E-ajoene, Z-ajoene, Allyl mercaptan.196 Structures of 
some important constituents of garlic are illustrated in Figure 12.
Amagase197  described  formation  of  thiosulfinates  such  as 
Allicin  through  the  enzymatic  reaction  of  sulfur-substituted 
cysteine sulfoxides, via sulfur-substituted sulfenic acids as a highly 
reactive intermediate.
According to the recent pharmacological findings, garlic is a 
preventive rather than therapeutic. The pharmacological effects of 
garlic have mostly been attributed to its hypoglycemic198 hypo-
lipidimic199  anticoagulant,  antihypertensive200  antihepatotoxic, 
anticancer, immune system modulatory, antiatherosclerotic, anti-
microbial, antidote (for heavy metal poisoning) and antioxidant 
properties.196,197 In addition to this, the bulb of garlic is used as 
an antirheumatic and stimulant beside its use in conditions like 
paralysis, forgetfulness, tumor colicky pain and chronic fever.201 
Recent studies have demonstrated that garlic exerts its therapeutic 
effect by increasing nitric oxide (NO) production.202,203
It is also found to have free radical scavenging action and inhibits 
oxidative modification of low-density lipoproteins.204 The intrinsic 
antioxidant activity of garlic, aged garlic extracts (AGE) and some 
garlic constituents have been widely documented in vivo205 and in 
vitro.206 LDL oxidation has been recognized as playing an impor-
tant role in the initiation and progression of atherosclerosis. Popov 
and Lewin,207 observed the antioxidant effect of the aqueous extract 
from a dehydrated garlic-powder preparation by using photochemi-
luminescence on the Cu(2+)-initiated oxidation of LDL. AGE and 
S-allylcysteine (SAC) inhibited both lactate-dehydrogenase release 
and lipid peroxidation induced by H2O2. It is also reported that garlic 
extract shows its antioxidant activity by increases SOD, glutathione 
peroxidase  and  catalase  activity  in  vascular  cell  and  culture.208-
211  Furthermore,  Geng  and  Lau,208  showed  that  AGE  increases   
intracellular glutathione levels, glutathione disulfide reductase, and 
SOD activity in bovine pulmonary artery endothelial cells, whereas 
the level of glutathione disulfide decreased. Geng et al.212 determined 
the effects of SAC on NFκB cultivation in human T lymphocytes 
(Jurkat cells) induced by tumor necrosis factor alpha and H2O2. 
SAC consistently inhibited NFκB activation induced by both tumor 
necrosis  factor  alpha  and  H2O2  in  nuclear  extracts. The  results 
suggest that SAC might act through antioxidant mechanisms to 
block NFκB activation in Jurkat cells. Allicin also inhibit the growth Antioxidants and metal toxicity
www.landesbioscience.com Oxidative Medicine and Cellular Longevity 203
  35.  Monterio HP, Bechara EJH, Abdalla DSP. Free radicals involvement in neurological 
porphyrias and lead poisoning. Mol Cell Biochem 1991; 103:73-83.
  36.  Tripathi RM, Raghunath R, Mahapatra S. Blood lead and its effect on Cd, Cu, Zn, Fe 
and hemoglobin levels of children. Sci Total Environ 2001; 277:161-8.
  37.  Nehru B, Dua R. The effect of dietary selenium on lead neurotoxicity. J Environ Pathol 
Toxicol Oncol 1997; 16:47-50.
  38.  Aykin-Burns  N,  Franklin  EA,  Ercal  N.  Effects  of  N-acetylcycteine  on  lead  exposed 
PC-12 cells. Arch Environ Contam Toxicol 2005; 49:119-23.
  39.  Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997; 272:19633-6.
  40.  Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to 
DNA: mechanisms and measurement. Free Rad Biol Med 2002; 32:1102-15.
  41.  Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21:361-70.
  42.  Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, 
mutation and disease. FASEB J 2003; 17:1195-214.
  43.  Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, 
malonaldehyde and related aldehydes. Free Rad Biol Med 1991; 11:81-128.
  44.  Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mut Res-Fund Mol 
Mech Mutagen 1999; 424:83-95.
  45.  Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mut Res Fund Mol 
Mech Mutagen 1999; 424:83-95.
  46.  Trueba  GP,  Sanchez  GM,  Giuliani  A.  Oxygen  free  radical  and  antioxidant  defense 
mechanism in cancer. Front Biosci 2004; 9:2029-44.
  47.  Stadtman ER. Protein oxidation and aging. Science 1992; 257:1220-4.
  48.  Stadtman ER. Metal ion-catalyzed oxidation of proteins-biochemical-mechanism and 
biological consequences. Free Rad Biol Med 1990; 9:315-25.
  49.  McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in 
humans? Free Rad Biol Med 1999; 26:1034-53.
  50.  Mates JM, Perez-Gomez C, De Castro IN. Antioxidant enzymes and human diseases. 
Clin Biochem 1999; 32:595-603.
  51.  Anderson O. Principles and recent developments in chelation treatment of metal intoxi-
cation. Chern Rev 1999; 99:2683-710.
  52.  Jones MM, Cherian MG. The search for chelate antagonists for chronic cadmium intoxi-
cation. Toxicology 1990; 62:1-25.
  53.  Mc Cord JM, Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein 
(hemocuprein). J Biol Chem 1969; 244:60409-55.
  54.  Mates JM, Perez-Gomez C, De Castro IN. Antioxidant enzymes and human diseases. 
Clin Biochem 1999; 32:595-603.
  55.  Young  IS,  Woodside  IS.  Antioxidants  in  health  and  disease.  J  Clin  Pathol  2001;   
54:176-86.
  56.  Kasparova S, Brezova V, Valko M, Horecky J, Mlynarik V, Liptaj T, et al. Study of the 
oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 2005; 
46:601-11.
  57.  Cuzzorcrea S, Thiemermann C, Salvemini D. Potential therapeutic effect of antioxidant 
therapy in shock and inflammation. Curr Med Chem 2004; 11:1147-62.
  58.  Jones DP, Kagan VE, Aust SD, Reed DJ, Omaye ST. Impact of nutrients on cellular lipid 
peroxidation and antioxidant defence system. Fund Appl Toxicol 1995; 26:1-7.
  59.  Halliwell B, Wasil M, Grootveld M. Biologically significant scavenging of the myeloper-
oxidase-derived oxidant hypochlorous acid by ascorbic acid. FEBS Lett 1987; 213:15-7.
  60.  Goyer RA, Cherian MG. Ascorbic acid and EDTA treatment of lead toxicity in rats. Life 
Sci 1979; 24:433-8.
  61.  Mahaffey KR, Michaelson JA. Interactions between lead and nutrition. In Low level of 
lead exposure. The Clinical Implication of Current Research (Needleman HL, Ed.,). 
Raven Press, New York 1980; 159-200.
  62.  Tajmir-Riahi  HA.  Coordination  chemistry  of  vitamin  C.  Part  II.  Interaction  of 
L-ascorbic acid with Zn(II), Cd(II), Hg(II) and Mn(II) ions in the solid state and in 
aqueous solution. J Inorg Biochem 1991; 42:47-55.
  63.  Suh J, Zhu BZ, Frei B. Ascorbate does not act as a pro-oxidant towards lipids and 
proteins in human plasma exposed to redox active transition metal ions and hydrogen 
peroxide. Free Rad Biol Med 2003; 34:1306-14.
  64.  You  WC,  Zhang  L,  Gail  MH,  Chang  YS,  Liu  WD,  Ma  JL,  et  al.  Gastric  cancer: 
Helicobacter pylori, serum Vitamin C, and other risk factors. J Natl Cancer Inst 2000; 
92:1607-12.
  65.  Lauwerys R, Roels H, Buchet JP. The influence of orally administered vitamin C or zinc 
on the absorption of and the biological response to lead. J Occup Med 1983; 25:668-78.
  66.  Simon JA, Hudes ES. Relationships of ascorbic acid to blood lead levels. J Am Med Assoc 
1999; 281:2289-93.
  67.  Dawson EB, Harris WA. Effect of ascorbic acid supplementation on blood lead levels. J 
Am Coll Nutr 1997; 16:480.
  68.  Knekt P, Jarvinen R, Seppanen R, Rissanen R, Aroma A, Heinonen OP, et al. Dietary 
antioxidants and the risk of lung-cancer. Am J Epidemiol 1991; 34:471-9.
  69.  Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad 
Sci 1989; 570:7-22.
  70.  Flora SJS. Nutritional components modify metal absorption, toxic response and chela-
tion therapy. J Nutri Environ Med 2002; 12:53-67.
  3.  Flora SJS, Saxena G, Mehta A. Reversal of lead-induced neuronal apoptosis by chela-
tion treatment in rats: role of ROS and intracellular Ca2+. J Pharmacol Exp Ther 2007; 
322:108-16.
  4  Watanabe  M,  Henmi  K,  Ogawa  K,  Suzuki  T.  Cadmium  dependent  generation  of 
reactive oxygen species and mitochondrial DNA breaks in photosynthetic and non-
photosynthetic strains of Euglena gracilis. Comp Biochem Physiol Toxicol Pharmacol 
2003; 134:227-34.
  5.  Dayan AD, Paine AJ. Mechanisms of chromium toxicity, carcinogenicity and allergenic-
ity: review of the literature from 1985 to 2000. Hum Exp Toxicol 2001; 20:439-51.
  6.  Lee YW, Ha MS, Kim YK. Role of reactive oxygen species and glutathione in inorganic 
mercury-induced injury in human glioma cells. Neurochem Res 2001; 26:1187-93.
  7.  Kalia K, Flora SJS. Strategies for Safe and Effective Treatment for Chronic Arsenic and 
Lead Poisoning. J Occup Hlth 2005; 47:1-21.
  8.  Cadenas E. Biochemistry of oxygen toxicity. Ann Rev Biochem 1989; 58:79-110.
  9.  Poli G, Leonarduzzi F, Biasi E. Chiarpotto Oxidative stress and cell signalling. Curr Med 
Chem 2004; 11:1163-82.
  10.  Halliwell B. Antioxidants in human health and disease. Ann Rev Nutr 1996; 16:33-50.
  11.  Gutteridge JM, Halliwell B. Iron toxicity and oxygen radicals. Baillieres Clin Haematol 
1989; 2:195-256.
  12.  Desideri A, Falconi M. Prokaryotic Cu, Zn superoxidase dismutase. Biochem Soc Trans 
2003; 6:1322-35.
  13.  Hlavaty JJ, Benner JS, Hornstra LJ, Schildkraut I. Identification of the metal-binding 
sites of restriction endonucleases by Fe2+ mediated oxidative stress. Biochemistry 2000; 
39:3097-105.
  14.  Wiseman H. Damage to DNA by reactive oxygen and nitrogen species: Role in inflam-
matory disease and progression to cancer. Biochem J 1996; 313:17-29.
  15.  Lynn S, Shiung JN, Gurr JR, Jan KY. Arsenite stimulates poly (ADP ribosylation) by 
generation of nitric oxide. Free Radic Biol Med 1998; 24:442-9.
  16.  Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, Riederer P, Becker Brain G. 
Iron pathways and their relevance to Parkinson’s disease. J Neurochem 2001; 79:225-36.
  17.  Siah CW, Trinder D, Olynyk JK. Iron overload. Clin Chim Acta 2005; 358:24-36.
  18.  Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, et al. Treatment of 
metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I 
study. Clin Cancer Res 2000; 6:1-10.
  19.  Leonard S, Gannett PM, Rojanasakul Y, Schwegler-Berry D, Castranova V, Vallyathan V, 
Shi XL. Cobalt-mediated generation of reactive oxygen species and its possible mecha-
nism. J Inorg Biochem 1998; 70:239-44.
  20.  Bucher JR, Hailey JR, Roycroft JR, Haseman JK, Sills RC, Grumbein SL, et al. Inhalation 
toxicity and carcinogenicity studies of cobalt sulfate. Toxicol Sci 1999; 49:56-67.
  21.  Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S. Oral exposure of 
dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase 
in 8-oxo-2-deoxyguanosine level, specifically in the target organs for arsenic carcinogen-
esis. Biochem Biophys Res Commun 2001; 287:66-70.
  22.  Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol 
Cell Biochem 2004; 255:67-78.
  23.  Pi J, Horiguchi S, Sun Y, Nikaido M, Shimojo N, Hayashi T. A potential mechanism for 
the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate 
in rabbits. Free Radical Biol Med 2003; 35:102-13.
  24.  Rin K, Kawaguchi K, Yamanaka K, Tezuka M, Oku N, Okada S. DNA-strand breaks 
induced  by  dimethylarsinic  acid,  a  metabolite  of  inorganic  arsenics,  are  strongly 
enhanced by superoxide anion radicals. Biol Pharm Bull 1995; 18:45-58.
  25.  Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response 
to oxidant stress in cultured mammalian cells. Can Res 1991; 51:974-8.
  26.  Liu XS, Athar M, Lippal I, Waldren C, Hei TK. Induction of oxyradicals by arsenic, 
implication for mechanism of genotoxicity. Proc Natl Acad Sci 2001; 98:1643-8.
  27.  Wen-Chien C, Hsuan-Yu C, Sung-Liang Y, Linzhao C, Pan-Chyr Y, Chi VD. Arsenic 
suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. 
Blood 2005; 106:304-10.
  28.  Waalkes MP, Liu J, Ward JM, Diwan LA. Mechanisms underlying arsenic carcinogenesis: 
hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 2004; 
198:31-8.
  29.  Schiller CM, Fowler BA, Woods JS. Effects of arsenic on pyruvate dehydrogenase activa-
tion. Environ Health Perspect 1977; 19:205-7.
  30.  Lawton LJ, Donaldson WE. Lead induced tissue fatty acid alterations and lipid peroxida-
tion. Biol Trace Elem Res 1991; 28:83-97.
  31.  Sandhir R, Gill KD. Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem 
Res 1995; 48:91-7.
  32.  Flora SJS. Lead in the Environment: Prevention and Treatment. J Environ Biol 2002; 
23:29-44.
  33.  Stohs ST, Bagchi D. Oxidative mechanism in the toxicity of metal ions. Free Rad Biol 
Med 1995; 18:321-36.
  34.  Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: 
mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001; 
1:529-39.Antioxidants and metal toxicity
204 Oxidative Medicine and Cellular Longevity 2009; Vol. 2 Issue 4
 101.  Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic Acid as a Potential 
Therapy for Chronic Diseases Associated with Oxidative Stress. Curr Med Chem 1994; 
11:1135-46.
 102.  Haenen  GR,  Bast  A.  Scavenging  of  hypochlorous  acid  by  lipoic  acid.  Biochem 
Pharmacol 1991; 42:2244-6.
 103.  Seaton TA, Jenner P, Marsden CD. The isomers of thioctic acid alter 14C-deoxyglocuse 
incorporation in rat basal ganglia. Biochem Pharmacol 1996; 51:983-6.
 104.  Shanthakumari D, Srinivasalu S, Subramanian S. Effect of fluoride intoxication on lipid 
peroxidation and antioxidant status in experimental rats. Toxicology 2004; 204:219-28.
 105.  NairJ,  De  Flora  S,  Izzotti  A,  Bartsch  H.  Lipid  peroxidation-derived  etheno-DNA 
adducts in human atherosclerotic lesions. Mutat Res 2007; 621:95-105.
 106.  Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, 
lipid peroxidation and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 
2007; 295:45-52.
 107.  Lovell MA, Xie C, Xiong S, Markesbery WR. Protection against amyloid beta peptide and 
iron/hydrogen peroxide toxicity by alpha lipoic acid. J Alzheimer’s Dis 2003; 5:229-39.
 108.  Kozlov AV, Gille L, Staniek K, Nohl H. Dihydrolipoic acid maintains ubiquinone in 
the antioxidant active form by two-electron reduction of ubiquinone and one-electron 
reduction of ubisemiquinone. Arch Biochem Biophys 1999; 363:148-54.
 109.  Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating anti-
oxidant? Biochem Pharmacol 1995; 50:123-6.
 110.  Liu J, Ames BN. Reducing mitochondrial decay with mitochondrial nutrients to delay 
and  treat  cognitive  dysfunction,  Alzheimer’s  disease  and  Parkinson’s  disease.  Nutr 
Neurosci 2005; 8:67-89.
 111.  Ames BN, Liu J, Atamna H, Hagen TM. Delaying the Mitochondrial Decay of Aging 
in the Brain. Clin Neurosci Res 2003; 2:331-8.
 112.  Suh JH, Wang H, Liu RM, Liu J, Hagen TM. (R)-Alpha-lipoic acid reverses the age-
related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine 
requirement for GSH synthesis. Arch Biochem Biophys 2004; 423:126-35.
 113.  Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, et al. Lipoic 
acid as a novel treatment for Alzheimer’s disease and related dementias. Pharmacol Ther 
2007; 113:154-64.
 114.  Miura K, Clarkson TW. Reduced methylmercury accumulation in a methyl mercury resis-
tant rat pheochromocytoma PC12 cell line. Toxicol Appl Pharmacol 1993; 118:39-45.
 115.  Shila S, Subathra M, Muthuswamy AD, Chinnakkannu P. Arsenic intoxication-induced 
reduction of glutathione level and of the activity of related enzymes in rat brain regions: 
reversal by DL-a-lipoic acid. Arch Toxicol 2005; 79:140-6.
 116.  Prescott LF. Paracetamol over dosage. Pharmacological considerations and clinical man-
agement. Drugs 1983; 25:290-314.
 117.  Bray GP, Tredger JM, Williams R. S-adenosylmethionine protects against APAP hepato-
toxicity in two mouse models. Hepatology 1992; 15:297-301.
 118.  Bridgeman MM, Marsden M, MacNee W, Flenley DC, Ryle AP. Cysteine and gluta-
thione concentrations in plasma and bronchoalveolar lavage fluid after treatment with 
N-acetylcysteine. Thorax 1991; 46:39-42.
 119.  Gurer H, Ozgunes H, Neal R, Spitz DR, Erçal N. Antioxidant effects of N-acetylcysteine 
and succimer in red blood cells from lead-exposed rats. Toxicology 1998; 128:181-9.
 120.  Corcoran  GB, Todd  EL,  Racz  WJ,  Hughes  H,  Smith  CV,  Mitchell  JR.  Effects  of 
N-acetylcysteine  on  the  disposition  and  metabolism  of  acetaminophen  in  mice.  J 
Pharmacol Exp Ther 1985; 232:857-63.
 121.  Banner W, Koch M, Capin DM, Hopf SB, Chang S, Tong TG. Experimental chelation 
therapy  in  chromium,  lead  and  boron  intoxication  with  N-acetylcysteine  and  other 
compounds. Toxicol Appl Pharmacol 1986; 83:142-7.
 122.  Martin DS, Willis SE, Cline DM. N-Acetylcysteine in the treatment of human arsenic 
poisoning. J Am Board Fam Pract 1990; 3:293-6.
 123.  Flora SJS. Arsenic induced oxidative stress and its turnover following combined admin-
istration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exp 
Pharmacol Physiol 1999; 26:865-9.
 124.  Modi  M,  Kaul  RK,  Kannan  GM,  Flora  SJS.  Co-administration  of  zinc  and 
N-acetylcysteine prevents arsenic induced tissue oxidative stress in male rats. J Trace 
Elem Med Biol 2006; 20:197-204.
 125.  Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in 
mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol 
Appl Pharmacol 2007; 15:146-55.
 126.  Ottenwalder S. Differential effect of N-acetylcysteine on excretion of the metals Hg, Cd, 
Pb and Au. Arch Toxicol 1987; 60:401-12.
 127.  Pande M, Mehta A, Pant BP, Flora SJS. Combined administration of a chelating agent 
and an antioxidant in the prevention and treatment of acute lead intoxication in rats. 
Environ Toxicol Pharmacol 2001; 9:173-84.
 128.  Neal R, Cooper K, Gurer H, Ercal N. Effect of N-acetylcysteine and 2,3-dimercaptosuc-
cinic acid on lead induced oxidative stress in rat lenses. Toxicology 1997; 130:167-74.
 129.  Neal R, Yang P, Fiecht J, Yildiz D, Gurer H, Ercal N. Pro-oxidant effects of d-aminole-
vulinic acid on Chinese Hamster Ovary cells. Toxicol Lett 1998; 91:169-78.
  71.  Kojo S. Vitamin C: basic metabolism and its function as an index of oxidative stress. 
Curr Med Chem 2004; 11:1041-106.
  72.  Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, Kayden HJ, et al. Human alpha-
tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. 
Biochem J 1995; 306:437-43.
  73.  Basu  TK,  Dickerson  JW.  Vitamin  E.  In:  Vitamins  in  human  health  and  disease. 
Wallingford UK: CAB International 1996; 214-27.
  74.  Lee TC, Ho IC. Modulation of cellular antioxidant defense activities by sodium arsenite 
inhuman fibroblasts. Arch Toxicol 1994; 69:498-504.
  75.  Flora SJS, Pande M, Mehta A. Beneficial effect of combined administration of some 
naturally  occurring  antioxidants  (vitamins)  and  thiol  chelators  in  the  treatment  of 
chronic lead intoxication. Chem Biol Interac 2003; 145:267-80.
  76.  Mittal M, Flora SJS. Vitamin E protects oxidative stress and essential metal imbalance 
during concomitant exposure to arsenic and fluoride in male mice. Drug Chem Toxicol 
2007; 30:263-81.
  77.  Ganther HE. Modification of methyl mercury toxicity and metabolism by selenium and 
vitamin E: possible mechanisms. Environ Health Perspect 1978; 25:71-6.
  78.  Abubakar MG, Taylor A, Ferns GA. Regional accumulation of aluminum in the rat brain 
is affected by dietary vitamin E. J Trace Elem Med Biol 2004; 18:53-9.
  79.  Dhawan M, Flora SJS, Tandon SK. Preventive and therapeutic role of vitamin E in 
chronic Plumbism. Biomed Environ Sci 1989; 2:335-41.
  80.  Gurer H, Ozgunes H, Neal R, Spitz DR, Ercal N. Antioxidant effects of N-acetylcysteine 
and succimer in red blood cells from lead exposed rats. Toxicology 1998; 128:181-9.
  81.  Weber P, Bendich A, Machlin LJ. Vitamin E and human health: rationale for determin-
ing recommended intake levels. Nutrition 1997; 13:450-60.
  82.  Flora SJS, Pande M, Mehta A. Beneficial effect of combined administration of some 
naturally  occurring  antioxidants  (vitamins)  and  thiol  chelators  in  the  treatment  of 
chronic lead intoxication. Chem Biol Interaction 2003; 145:267-80.
  83.  White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supple-
ment use and colon cancer. Cancer Epidemiol Biomark 1997; 6:769-74.
  84.  Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH. Clinical-trial 
of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331:141-7.
  85.  Masella  R,  Di  Benedetto  R, Vari  R,  Filesi  C,  Giovannini  C.  Novel  mechanisms  of 
natural antioxidant compounds in biological systems: involvement of glutathione and 
glutathione-related enzymes. J Nutr Biochem 2005; 16:577-86.
  86.  Karoui  H,  Hogg  N,  Frejaville  C,  Tordo  P,  Kalyanaraman  B.  Characterization  of 
sulfur-centered radical intermediates formed during the oxidation of thiols and sulfite 
by peroxynitrite-ESR-SPIN trapping and oxygen uptake studies. J Biol Chem 1996; 
271:6000-9.
  87.  Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplas-
mic-reticulum. Science 1992; 57:1496-502.
  88.  Kagan  V,  Shvedova  A,  Serbinova  E,  Khan  S,  Swanson  C,  Powell  R,  Packer  L. 
Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous 
phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 
1992; 44:1637-49.
  89.  Bast  A,  Haenen  GR.  Lipoic  acid:  a  multifunctional  antioxidant.  Biofactors  2003; 
17:207-13.
  90.  Cremer DR, Rabeler R, Roberts A, Lynch B. long-term safety of alpha-lipoic acid (ALA) 
consumption: A 2-year study. Long Regul Toxicol Pharmacol 2006; 46:193-201.
  91.  Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. 
Gen Pharmacol 1997; 29:315-31.
  92.  Packer L, Roy S, Sen CK. Alpha-lipoic acid: a metabolic antioxidant and potential redox 
modulator of transcription. Adv Pharmacol 1997; 38:79-101.
  93.  Persson HL, Svensson AI, Brunk UT. Alpha Lipoic Acid and Other Antioxidants May 
Prevent Cell Death by Chelating Metals. Redox Rep 2001; 6:327-34.
  94.  Packer L, Tritschler HJ, Wessel K. Neuropretection by the metabolic antioxidant alpha-
lipoic acid. Free Rad Biol Med 1997; 22:359-78.
  95.  Panigrahi M, Sadguna Y, Shivakumar BR, Kolluri SV, Roy S, Packer L. Alpha-Lipoic acid 
protects against reperfusion injury following cerebral ischemia in rats. Brain Res 1996; 
717:184-8.
  96.  Haenen GR, Vermeulen NPE, Timmerman H, Bast A. Effect of thiols on lipid peroxida-
tion in rat liver microsomes. Chem Biol Interact 1989; 71:201-12.
  97.  Sadi G, Yılmaz O, Guray T. Effect of vitamin C and lipoic acid on streptozotocin-
induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and 
Catalase. Mol Cell Biochem 2008; 309:109-16.
  98.  Padayatty SJ, Daruwala R, Wang YY. Vitamin C: from molecular actions to optimum 
intake.  In:  Cadenas  E,  Packer  L,  (eds.,)  Handbook  of  antioxidants  (oxidative  stress 
and disease) CRC, Marcel Dekker, Inc., New York Basel Taylor & Francis Group LLC 
2002.
  99.  Baydas  G,  Donder  E,  Kiliboz  M,  Sonkaya  E, Tuzcu  M,  Yasar  A,  Nedzvetskii  VS. 
Neuroprotection by α-Lipoic Acid in Streptozotocin_Induced Diabetes. Biochemistry 
2004; 69:1001-5.
 100.  Bhatt K, Flora SJS. Oral co-administration of α-lipoic acid, quercetin and captopril 
prevents gallium arsenide toxicity in rats. Environ Toxicol Pharmacol 2009; 28:140-6.Antioxidants and metal toxicity
www.landesbioscience.com Oxidative Medicine and Cellular Longevity 205
 161.  Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. 
Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven 
countries study. Arch Intern Med 1995; 155:381-6.
 162.  Sellappan S, Akoh C. Flavonoids and antioxidant capacity of Georgia grown Vidalia 
onions. J Agric Food Chem 2002; 50:5338-42.
 163.  Lee K, Kim Y, Kim D. Major phenolics in apple and their contribution to the total 
antioxidant capacity. J Agric Food Chem 2003; 51:6516-20.
 164.  Boer V, Dihal A, Woude H. Tissue distribution of quercetin in rats and pigs. J Nutr 
2005; 135:1718-25.
 165.  Negre-Salvagyre A, Salvagyre R. Quercetin prevents the cytotoxicity of oxidized low-
density lipoproteins by macrophages. Free Radic Biol Med 1992; 12:101-6.
 166.  Sichel G, Corsaro C, Scalia M, Di Bilio AJ, Bonomo RP. In vitro scavenger activity of 
some flavonoids and melanins against LDLP. Free Radic Biol Med 1991; 11:1-8.
 167.  Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. 
Environ Hlth Perspect 1995; 103:103-12.
 168.  Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. 
Food Chem Toxicol 1995; 33:1061-80.
 169.  Schroeter H, Boyd C, Spencer JP, Williams RJ, Cadenas E, Rice-Evans C. MAPK signal-
ing in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 
2002; 23:861-80.
 170.  Ong CS, Tran E, Nguyen TT, Ong CK, Lee SK, Lee JJ, et al. Quercetin-induced growth 
inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in 
bad and hypophosphorylated retinoblastoma expressions. Oncol Rep 2004; 11:727-33.
 171.  Braganhol  E,  Zamin  LL,  Canedo  AD,  Horn  F, Tamajusuku  AS,  Wink  MR,  et  al. 
Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer 
Drugs 2006; 17:663-71.
 172.  Chen TJ, Jeng JY, Lin CW, Wu CY, Chen YC. Quercetin inhibition of ROS-dependent 
and -independent apoptosis in rat glioma C6 cells. Toxicology 2006; 223:113-26.
 173.  Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. The 
J Nutr 2003; 133:3248-54.
 174.  Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism 
and structure-activity relationships. J Nutr Biochem 2002; 13:572-84.
 175.  Amanda CG, Marcelo HG. Time resolved fluorescence spectroscopy of quercetin and 
morin complexes with Al3+. Spectrochim Acta Part A: Molecular and Biomolecular. 
Spectroscopy 2002; 58:83-9.
 176.  Hedda M, Susanne F. Transcriptional analysis of the queD gene coding for quercetinase 
of Streptomyces sp., FLA. FEMS Microbiol Lett 2001; 287:100-7.
 177.  Kuntic  V,  Blagojevic  S,  Malesev  D,  Radovic  Z,  Bogavac  M.  Spectrophotometric 
Investigation  of  the  Pd(II)-Quercetin  Complex  in  50%  Ethanol.  Chemical  1998; 
129:41-8.
 178.  Bravo A, Anacona JR. Metal complexes of the flavonoid quercetin: antibacterial proper-
ties. Trans metal Chem 2001; 26:20-3.
 179.  Balcerzak M, Kopacz M, Kosiorek A, Swiecicka E, Kus S. Spectrophotometric studies of 
the interaction of noble metals with quercetin and quercetin-5'-sulfonic acid. Anal Sci 
2004; 20:1333-47.
 180.  Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutri-
ents. The FASEB J 1987; 1:441-5.
 181.  Hollman PCH, Katan MB. Absorption, metabolism and health effects of dietary fla-
vonoids in man. Biomed Pharmacother 1997; 51:305-10.
 182.  Kahl R, Hildebrandt AG. Methodology for studying antioxidant activity and mecha-
nisms of action of antioxidants. Food Chem Toxicol 1986; 24:1007-14.
 183.  Balazs  L,  Leon  M.  Evidence  of  an  oxidative  challenge  in  the  Alzheimer’s  brain. 
Neurochem Res 1994; 19:1131-7.
 184.  Ansari MA. Protective effect of quercetin in primary neurons against Aβ (1-42): rel-
evance to Alzheimer’s disease. J Nutr Biochem 2008; 23:23-32.
 185.  Sakanashi Y. Possible use of quercetin, an antioxidant, for protection of cells suffering 
from overload of intracellular Ca2+: a model experiment. Life Sci 2008; 83:164-9.
 186.  Graf B. Flavonols, flavones, flavanones and human health: epidemiological evidence. J 
Med Food 2005; 8:281-90.
 187.  Mariani C. Flavonoid characterization and in vitro antioxidant activity of Aconitum 
anthora L. (Ranunculaceae). Phytochem 2008; 69:1220-6.
 188.  Murota K, Terao J. Antioxidative flavonoid quercetin: implications of its intenstinal 
absorption and metabolism. Arch Biochem Biophy 2003; 417:12-7.
 189.  Bouktaib M. Regio- and stereoselective synthesis of the major metabolite of quercetin, 
quercetin-3-O-b-D-glucuronide. Tetrahedr Lett 2003; 43:6263-6.
 190.  Begum AN, Terao J. Protective effect of quercetin against cigarette tar extract-induced 
impairment of erythrocyte deformability. J Nutr Biochem 2002; 13:265-72.
 191.  Park YH, Chiou GC. Structure-activity relationship (SAR) between some natural fla-
vonoids and ocular blood flow in the rabbit. J Ocul Pharmacol Ther 2004; 20:35-42.
 192.  Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercit-
rin prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 
1 gene expression in macrophages. Biochem Pharmacol 2005; 69:1839-51.
 193.  Mishra D, Flora SJS. Quercetin administration during chelation therapy protects arsenic 
induced oxidative stress in mouse. Biol Trace Elem Res 2008; 122:137-47.
 130.  Flora SJS, Tripathi N, Kannan GM. Arsenic induced biochemical alterations and their 
reversibility following chelation therapy in rats. Poisoning control and Environ Toxicol 
2000; 29-37.
 131.  Brakenhoff JP, Commandeur JN, Wormhoult LW, Groot EJ, Vermeulen NP. Molecular 
mechanism of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver 
fractions. Carcinogenesis 1996; 17:715-24.
 132.  Vermeulen NP, Commandeur JN, Groot EJ, Wormhoult LW, Ramnatshing S, Li OJ, 
Brakenhoff JP. Toxicity of fotemustine in rat hepatocytes and mechanism-based protec-
tion against it. Chem Biol Interact 1998; 110:135-49.
 133.  Olive  MF.  Interactions  between  taurine  and  ethanol  in  the  central  nervous  system. 
Amino Acids 2002; 23:345-57.
 134.  Tsuji A, Tamai I. Sodium- and chloride-dependent transport of taurine at the blood-
brain barrier. Adv Exp Med Biol 1996; 403:385-91.
 135.  Salimaki J, Scriba G, Piepponen TP, Rautolahti N, Ahtee L. The effects of systemi-
cally administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and 
taurine in freely moving rats. Naunyn-Schmiedeberg’s Archives of Pharmacology 2003; 
368:134-41.
 136.  Dominy J Jr, Thinschmidt JS, Peris J, Dawson R Jr, Papke RL. Taurine-induced long-
lasting  potentiation  in  the  rat  hippocampus  shows  a  partial  dissociation  from  total 
hippocampal  taurine  content  and  independence  from  activation  of  known  taurine 
transporters. Journal of Neurochemistry 2004; 89:1195-205.
 137.  Birdsall TC. Therapeutic applications of taurine. Alt Med Rev 1998; 3:128-36.
 138.  Foos TM, Wu JY. The role of taurine in the central nervous system and the modulation 
of intracellular calcium homeostasis. Neurochem Res 2002; 27:21-6.
 139.  Leon R, Wu H, Jin Y, Wei J, Buddhala C, Prentice H, Wu JY. Protective function of tau-
rine in glutamate-induced apoptosis in cultured neurons. J Neurosci Res 2008; 23:31-9.
 140.  Gurer H, Ozgunes H, Saygin E, Ercal N. Antioxidant effect of taurine against lead-
induced oxidative stress. Arch Environ Contam Toxicol 2001; 41:397-402.
 141.  Sinha M, Manna P, Sil PC. Taurine protects the antioxidant defense system in the eryth-
rocytes of cadmium treated mice. BMB Reports 2008; 41:657-63.
 142.  Flora SJS, Chouhan S, Kannan GM, Mittal M, Swarnakar H. Combined administration 
of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats. 
Oxid Med Cell Long 2008; 1:39-45.
 143.  Zahorodnyi MI, Nebesna TI. Molecule of taurine and its quantum-pharmacological 
properties. Lik Sprava 1998; 5:103-8.
 144.  Huxtable RJ. Physiological action of Taurine. Physiol Rev 1992; 72:101-63.
 145.  Park T, Kyungshin L, Youngsook U. Dietary Taurine supplementation reduces plasma 
and liver cholesterol and triglyceride concentration in rats fed a high cholesterol diet. 
Nutr Res 1998; 18:1559-71.
 146.  Kerai MDJ. Reversal of ethanol induced hepatic steatosis and lipid peroxidation by 
taurine: a study in rats. Alc Alcoholism 1999; 34:529-41.
 147.  Waterfield CJ, Turton JA, Scales MDC, Timbrell JA. Reduction of liver Taurine in rats by 
β-alanine treatment increases carbon tetrachloride toxicity. Toxicology 1993; 77:7-20.
 148.  Redmond HP, Wang JH, Bouchier-Hayes D. Taurine attenuates nitric oxide and reactive 
oxygen intermediate dependent hepatocyte injury. Archives of Surgery 1996; 131:1287-8.
 149.  Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of 
taurine. General Pharmacology 1995; 26:453-62.
 150.  Wright CE, Tallan HH, Linn YY. Taurine: biological update. Ann Rev Biochem 1986; 
55:427-53.
 151.  Cozzi R, Ricordy R, Bartolini F. Taurine and ellagic acid: two differently acting natural 
antioxidants. Environ Mol Mutagen 1995; 26:248-54.
 152.  Gordon  RE,  Heller  RF. Taurine  protection  of  lungs  in  hamster  models  of  oxidant 
injury. A morphological time study of paraquat and bleomycin treatment. In: Taurine 
nutritional value and mechanism of action. Lombardini JB, Schaffer SW, Azuma J, Eds. 
Plenum Press, New York 1992; 319-23.
 153.  Flora SJS, Pande M, Bhadauria S, Kannan GM. Combined administration of taurine 
and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in 
rats. Hum Exp Toxicol 2004; 23:157-66.
 154.  Mortensen A, Skibsted LH, Truscott TG. The interaction of dietary carotenoids with 
radical species. Arch Biochem Biophys 2001; 385:13-9.
 155.  Burton GW, Ingold KU. Beta-carotene-an unusual type of lipid antioxidant. Science 
1984; 224:569-73.
 156.  Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A. Sharoni Lycopene 
interferes with cell cycle progression and insulin-like growth factor I signaling in mam-
mary cancer cells. Nutr Cancer Int J 2000; 36:101-11.
 157.  RiceEvans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of 
flavonoids and phenolic acids. Free Rad Biol Med 1996; 20:933-56.
 158.  Rice-Evans C. Flavonoid antioxidants. Curr Med Chem 2001; 8:797-807.
 159.  Schroeter H, Boyd C, Spencer JPE, Williams RJ, Cadenas E, Rice-Evans C. MAPK 
signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol 
Aging 2002; 23:861-80.
 160.  Polovka M, Brezova V, Stasko A. Antioxidant properties of tea investigated by EPR 
spectroscopy. Biophys Chem 2003; 106:39-56.Antioxidants and metal toxicity
 194.  Agarwal KC. Therapeutic action of garlic constituents. Med Res Rev 1996; 16:111-24.
 195.  Fujiwara  M,  Yishimura  M,  Tsuno  S,  Murakami  F.  “Allithiamine,”  a  newly  found 
derivative of vitamin B1 IV. on the alliin homologues in the vegetables. J Biochem 1958; 
45:141-9.
 196.  Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: the good, the bad and 
the ugly. Phytothe Res 2003; 17:97-106.
 197.  Amagase H. Clarifying the real bioactive constituents of garlic. J Nutr 2006; 136:716-25.
 198.  Augusti KT, Sheela CG. Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin 
secretagogue, in diabetic rats. Experientia 1996; 15:115-20.
 199.  Ismail MF, Gad MZ, Hamdy MA. Study of the hypolipidemic properties of pectin, garlic 
and ginseng in hypercholesterolemic rabbits. Pharmacol Res 1999; 39:157-66.
 200.  Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovas-
cular disease: clinical considerations. Arch Intern Med 1998; 9:2225-34.
 201.  Nadkarni  AK.  Indian  Materia  Medica  I  and  II.  Popular  Prakashan,  Bombay  1992; 
66-71.
 202.  Maslin CA, Brown ID, Xia-Hua Z. Nitric oxide a mediator of garlic action? Biochem 
Soc Transact 1997; 25:408.
 203.  Sooranna SR, Hirani J, Das I. Garlic can induce both GTP cyclohydrolase and nitric 
oxide synthase activity in choriocarcinoma cells. Biochem Soc Trans 1995; 23:543.
 204.  Nagatoshi I, Audowin BN, Benjamin HSL. Aged garlic extract and its constituents 
inhibit Cu2+-induced oxidative modification of low-density lipoproteins. Planta Medica 
1997; 63:263-4.
 205.  Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D, Weiner L. The 
mode of action of allicin: trapping of radicals and interaction with thiol containing 
proteins. Biochim Biophys Acta 1998; 1379:233-44.
 206.  Iqbal M, Athar M. Attenuation of Iron-Nitrilotriacetate (Fe-NTA)-mediated renal oxida-
tive stress, toxicity and hyperproliferative response by prophylactic treatment of rats with 
garlic oil. Food Chem Toxicol 1998; 36:485-95.
 207.  Popov I, Lewin G. Antioxidant effects of aqueous garlic extract. 2nd communication: 
inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittel 
forschung 1994; 44:604-7.
 208.  Geng S, Lau BH. Aged garlic extract modulates glutathione redox cycle and superoxide 
dismutase activity in vascular endothelial cells. Phytother Res 1997; 11:54-66.
 209.  Wei  Z,  Lau  BHS.  Garlic  inhibits  free  radical  generation  and  augments  antioxidant 
enzyme activity in vascular endothelial cells. Nutr Res 1998; 18:61-70.
 210.  Numagami Y, Sato S, Ohnishi T. Attenuation of rat ischemic brain damage by aged 
garlic extracts: a possible protecting mechanism as antioxidants. Neurochem Int 1996;   
29:135-43.
 211.  Yamasaki T, Lau BHS. Garlic compounds protect vascular endothelial cells from oxidant 
injury. Folia Pharmacol Jpn 1997; 110:138-41.
 212.  Geng Z, Rong Y, Lau BH. S-allyl cysteine inhibits activation of nuclear factor kappaB in 
human T cells. Free Radic Biol Med 1997; 23:345-50.
 213.  Oommen S, Anto RJ, Srinivas G, Karunagaran D. Allicin (from garlic) induces caspase-
mediated apoptosis in cancer cells. Europ J Pharmacol 2004; 485:97-103.
 214.  Horie T, Murayama T, Mishima T, Itoh F, Minamide Y, Fuwa T, Awazu S. Protection of 
liver microsomal membranes from lipid peroxidation by garlic extract. Planta Med 1989; 
55:506-8.
 215.  Senapati SK, Dey S, Dwivedi SK, Swarup D. Effects of garlic (Allium sativum L.) on 
tissue lead levels in rats. J Ethnopharmacol 2001; 76:229-32.
 216.  Choudhury AR, Das T, Sharma A, Talukder D. Use of crude extract of garlic (Allium 
sativum L.) in reducing cytotoxic effects of arsenic in mouse bone marrow. Phtother Res 
1993; 7:163-6.
 217.  Choudhury AR, Das T, Sharma A, Talukder G. Dietary garlic extract in modifying 
clastogenic effects of inorganic arsenic in mice: two generation studies. Mut Res 1996; 
359:165-70.
 218.  Flora SJS, Mehta A, Gupta R. Prevention of arsenic induced hepatic apoptosis by concom-
itant administration of garlic extracts in mice. Chem Biol Interac 2009; 177:227-33.
 219.  Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioac-
tive components. J Nutr 2001; 131:955-62.
 220.  Lawson LD, Ransom DK, Hughes BG. Inhibition of whole blood platelet aggregation 
by compounds in garlic clove extracts and commercial garlic products. Throm Res 1992; 
65:141-56.
 221.  Chowdhury R, Dutta A, Chaudhri SR, Sharma N, Giri AK, Chaudhri K. In vitro and in 
vivo reduction of sodiumarsenite induced toxicity by aqueous garlic extract. Food Chem 
Toxicol 2008; 46:740-51.
 222.  Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L. The mode of action of 
allicin: its ready permeability through phospholipid membranes may contribute to its 
biological activity. Biochem Biophys Acta 2000; 1463:20-30.
 223.  Flora SJS, Flora GJS, Saxena G. Environmental occurrence, health effects and manage-
ment of lead poisoning. In Lead: Chemistry, Analytical Aspects, Environmental Impacts 
and Health Effects. Cascas SB, Sordo J, Eds., Elsevier Publication, Netherlands 2006; 
158-228.
 224.  Flora SJS, Bhatt K, Mehta A. Arsenic moiety in gallium arsenide is responsible for 
neuronal apoptosis and behavioral alterations in rats. Toxicol Appl Pharmacol 2009; In 
press.
206 Oxidative Medicine and Cellular Longevity 2009; Vol. 2 Issue 4